BIRC5 and neuroblastoma: Many of these, e.g. NME1, PYCR1, TK1, BIRC5 and TOP2A, are located on Chr 17q, are upregulated in unfavorable neuroblastoma and associated with poor patient outcome [12, 18, 76–78].